You have 9 free searches left this month | for more free features.

Pharmacokinetic-Moedeling

Showing 1 - 25 of 6,082

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

TB Drugs and Bacterial Drug Resistance

Completed
  • Tuberculosis
  • Non-Tuberculosis Mycobacteria
    • Bethesda, Maryland
    • +1 more
    Mar 25, 2022

    Healthy Subjects Trial in Shanghai (JYP0061, )

    Completed
    • Healthy Subjects
    • Shanghai, Shanghai, China
      Shanghai Xuhui District Central Hospital
    Nov 16, 2023

    Based on Quantitative Pharmacology in Patients With Lenalidomide

    Recruiting
    • Multiple Myeloma
    • +2 more
      • Jinan, Shandong, China
        the First Affiliated Hospital of Shandong First Medical Universi
      Oct 3, 2023

      Carbapenem Resistant Klebsiella Pneumoniae Trial in Ratchathewi (Dose-adjustment by PKPD)

      Recruiting
      • Carbapenem Resistant Klebsiella Pneumoniae
      • Dose-adjustment by PKPD
      • Ratchathewi, Bangkok, Thailand
        Phramongkutklao Hospital
      May 7, 2023

      Based on Quantitative Pharmacology in Patients With Pamipril

      Not yet recruiting
      • Ovarian Cancer
        • (no location specified)
        Apr 28, 2023

        Infertility Trial in Chengdu, (GenSci094)

        Recruiting
        • Infertility
        • Chengdu,, Sichuan, China
          Chengdu Xinhua Hospital, affiliated with Sichuan North Medical C
        Oct 18, 2023

        Myelofibrosis Trial in Changsha (Jaktinib Hydrochloride Tablets)

        Not yet recruiting
        • Myelofibrosis
        • Jaktinib Hydrochloride Tablets
        • Changsha, Hunan, China
          The Third Hospital of Changsha
        Nov 9, 2023

        Hypertension Trial (CKD-828, D064, D701)

        Not yet recruiting
        • Hypertension
        • CKD-828, D064, D701
        • (no location specified)
        Apr 18, 2023

        Hypertension Trial (CKD-828, D064, D702)

        Not yet recruiting
        • Hypertension
        • CKD-828, D064, D702
        • (no location specified)
        May 21, 2023

        Asthma Trial in Beijing (GR2002 injection, Placebo)

        Recruiting
        • Asthma
        • GR2002 injection
        • Placebo
        • Beijing, China
          Peking University People's Hospital
        Jul 13, 2023

        Healthy Volunteers Trial (DWJ1543, DWC202216)

        Not yet recruiting
        • Healthy Volunteers
        • (no location specified)
        Jul 21, 2023

        Diabetes type2 Trial in Seoul (D745, D759, D150)

        Not yet recruiting
        • Diabetes type2
        • D745, D759, D150
        • Seoul, Korea, Republic of
          Catholic Hospital, Seoul
        Jun 26, 2023

        Type 2 Diabetes Trial in Beijing (HSK7653 10 mg, HSK7653 25 mg, HSK7653 50 mg)

        Completed
        • Type 2 Diabetes Mellitus
        • HSK7653 10 mg
        • +3 more
        • Beijing, Beijing, China
          Peking university people's hospital
        Sep 23, 2023

        Healthy Trial in Wuhan (Tegoprazan, Bismuth, Amoxicilli)

        Completed
        • Healthy
        • Wuhan, Hubei, China
          Union Hospital, Tongji Medical College, Huazhong University of S
        Jun 22, 2023

        Gastro Esophageal Reflux Trial (Lansoprazole 15 mg, Lansoprazole 15mg/Calcium carbonate 600mg)

        Not yet recruiting
        • Gastro Esophageal Reflux
        • Lansoprazole 15 mg
        • Lansoprazole 15mg/Calcium carbonate 600mg
        • (no location specified)
        Sep 3, 2023

        Pharmacokinetics Trial (WCK 2349 Oral, Placebo Oral)

        Completed
        • Pharmacokinetics
        • WCK 2349 Oral
        • Placebo Oral
        • (no location specified)
        Nov 28, 2022

        Eye Diseases, Presbyopia, Refractive Errors Trial in Newport Beach (Aceclidine + Brimonidine, Aceclidine)

        Recruiting
        • Eye Diseases
        • +5 more
        • Newport Beach, California
          Site #101
        Jul 7, 2023

        Hypertension, Diabetes, Type 2 Trial in Seoul (THP-00101 (Dapagliflozin) 10mg, THP-00102 (Telmisartan) 80mg)

        Recruiting
        • Hypertension
        • Diabetes Mellitus, Type 2
        • THP-00101 (Dapagliflozin) 10mg
        • THP-00102 (Telmisartan) 80mg
        • Seoul, Korea, Republic of
          H Plus Yangji Hospital
        Sep 25, 2023

        Severe Hemophilia A Without Inhibitor, Joint Bleed Trial in Bangkok ("Emicizumab", "HEMLIBRA®")

        Recruiting
        • Severe Hemophilia A Without Inhibitor
        • Joint Bleed
        • "Emicizumab", "HEMLIBRA®"
        • Bangkok, Thailand
          King Chulalongkorn Memorial hospital
        Nov 25, 2023

        Type 2 Diabetes Trial (Acetaminophen/SHR20004, Acetaminophen/Placebo)

        Not yet recruiting
        • Type 2 Diabetes Mellitus
        • (no location specified)
        Nov 17, 2023

        MDS Trial in Hangzhou (IV Decitabine, Decitabine and cedazuridine, only Decitabine and cedazuridine)

        Recruiting
        • Myelodysplastic Syndromes
        • IV Decitabine
        • +2 more
        • Hangzhou, Zhejiang, China
          The First Affiliated Hospital,Zhejiang University School of Medi
        Oct 23, 2023

        Peripheral Artery Disease Trial in Perth (BRight DCB)

        Not yet recruiting
        • Peripheral Artery Disease
        • BRight DCB
        • Perth, WAUS, Australia
          Royal Perth Hospital
        Oct 2, 2023

        HIV-1 Trial in Beijing (1 mg CL-197 capsules or CL-197 , 10 mg CL-197 capsules or CL-197 , 30 mg CL-197 capsules or CL-197 )

        Recruiting
        • HIV-1
        • 1 mg CL-197 capsules or CL-197 placebo
        • +4 more
        • Beijing, Beijing, China
          The Fifth Medical Center of Chinese PLA General Hospital
        Jul 12, 2023

        Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)

        Not yet recruiting
        • Serous Ovarian Cancer
        • Advanced Ovarian Cancer
        • (no location specified)
        Sep 20, 2023

        Hyperlipidemias Trial in Seoul (AD-104-A)

        Not yet recruiting
        • Hyperlipidemias
        • Seoul, Jongno-gu, Korea, Republic of
          Seoul National University Hospital
        Jan 26, 2023